Caspase-1 Inhibition Impacts the Formation of Chondrogenic Nodules, and the Expression of Markers Related to Osteogenic Differentiation and Lipid Metabolism

Abstract

Caspase-1, as the main pro-inflammatory cysteine protease, was investigated mostly with respect to inflammation-related processes. Interestingly, caspase-1 was identified as being involved in lipid metabolism, which is extremely important for the proper differentiation of chondrocytes. Based on a screening investigation, general caspase inhibition impacts the expression of Cd36 in chondrocytes, the fatty acid translocase with a significant impact on lipid metabolism. However, the engagement of individual caspases in the effect has not yet been identified. Therefore, the hypothesis that caspase-1 might be a candidate here appears challenging. The primary aim of this study thus was to find out whether the inhibition of caspase-1 activity would affect Cd36 expression in a chondrogenic micromass model. The expression of Pparg, a regulator Cd36, was examined as well. In the caspase-1 inhibited samples, both molecules were significantly downregulated. Notably, in the treated group, the formation of the chondrogenic nodules was apparently disrupted, and the subcellular deposition of lipids and polysaccharides showed an abnormal pattern. To further investigate this observation, the samples were subjected to an osteogenic PCR array containing selected markers related to cartilage/bone cell differentiation. Among affected molecules, Bmp7 and Gdf10 showed a significantly increased expression, while Itgam, Mmp9, Vdr, and Rankl decreased. Notably, Rankl is a key marker in bone remodeling/homeostasis and thus is a target in several treatment strategies, including a variety of fatty acids, and is balanced by its decoy receptor Opg (osteoprotegerin). To evaluate the effect of Cd36 downregulation on Rankl and Opg, Cd36 silencing was performed using micromass cultures. After Cd36 silencing, the expression of Rankl was downregulated and Opg upregulated, which was an inverse effect to caspase-1 inhibition (and Cd36 upregulation). These results demonstrate new functions of caspase-1 in chondrocyte differentiation and lipid metabolism-related pathways. The effect on the Rankl/Opg ratio, critical for bone maintenance and pathology, including osteoarthritis, is particularly important here as well.

Pyroptosis: A Novel Intervention Target in the Progression of Osteoarthritis

“…Therefore, caspase-1 direct inhibitors may also be a promising research direction in the future, under circumstances that can be distinguished from the former two inhibitors. 117…”

Analysis of Spontaneous and Induced Osteogenic Differentiation in 3D-micromasses of Human Multipotent Stem Cells

“…These cells then produce the components of extracellular matrix themselves. Furthermore, cells cultured in micromasses show a pronounced osteogenic differentiation compared to other carrier materials (16). A crucial protein associated with osteogenic differentiation of bone marrow stromal cells (BMSCs) is runtrelated transcription factor 2 (RUNX2).…”

Caspase-9 Is a Positive Regulator of Osteoblastic Cell Migration Identified by diaPASEF Proteomics

“…We and others have described nonapoptotic functions of caspases in osteogenesis and bone homeostasis as well. Treatment with the inhibitor of caspase-3 (CASP-3) accelerated bone loss in ovariectomized mice, Bmp4-induced osteoblastic differentiation of MC3T3-E1 is associated with increased activity of caspases-2, -3, and -8, and pharmacological and genetic inhibition of caspase-8 inhibited differentiation of these cells by reducing osteocalcin expression. , Inhibition of other caspases (-1, -7, and -12) modulated bone and hard tissue homeostasis, osteoblastic differentiation and expression of osteogenic and chondrogenic markers in various models in vivo and in vitro . − …”